Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
biotech
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
new york blog main
alirocumab
alnylam pharmaceuticals
amgen
apps
artificial intelligence
birth control
boston
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
contraception
daniel o'day
europe
european union
evolocumab
fertility
foundation medicine
foundationone cdx
foundationone heme
genentech
health
inclisiran
mobile
natural cycles
new york
new york top stories
novartis
osimertinib
pcsk9
What
agreed
3
×
acquire
billion
agency
app
big
brings
broad
cash
cholesterol
clarify
closed
company
compound
confidence
contraception
cycles
data
deal
didn’t
digital
drug
failing
fda
foundation
gain
genentech
investigation
medco
medical
medicine
medicines
momentum
month
morning
multi
natural
new
novartis
number
Language
unset
Current search:
agreed
×
fda
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@techcrunch.com
5 years ago
Natural Cycles contraception app told to clarify pregnancy risks
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
